US 11306077
Compounds, compositions and methods
granted A61PA61P25/00A61P25/28
Quick answer
US patent 11306077 (Compounds, compositions and methods) held by DENALI THERAPEUTICS INC. expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 47
- CPC classes
- A61P, A61P25/00, A61P25/28, A61P35/00